14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
The Minnesota Supreme Court recently issued a decision that altered the rules on when the clock star...
Read More >
How a transaction gets structured raises a multitude of issues, including whether the transaction mi...
Read More >
On August 6, 2014, plaintiff-relator Andrew Scollick filed a complaint in the United States District...
Read More >
In its resolution dated 20 November 2019, the Supreme Court concluded that an agreement must not pro...
Read More >
The Federal Trade Commission and the Antitrust Division of the Department of Justice are making clea...
Read More >
Where does creativity fit into compliance? In more places than you think. Problem-solving, accountab...
Read More >